Spiked “Supplements” For Diabetes, Pain On The Rise
This article was originally published in The Tan Sheet
Executive Summary
FDA is seeing supplements spiked with Rx ingredients indicated for pain management and diabetes treatment, and needs industry help identifying violators, CFSAN head Michael Landa says.
You may also be interested in...
In Brief
Hi-Tech OTC sales fall; social media posts prompt FDA warning; FDA warns PruTect Rx about claims; study finds no DMAA in geranium oil; prebiotic recall spreads to Eco Health product; more news In Brief.
Regulatory News In Brief
FDA warns Healing Ways to register facility; Dragon Herbs warned for tradeshow materials; BNE recalls ephedra-spiked supplements; supplement flu prevention claims cross the line; more regulatory news in brief.
FDA Expects STD Claims Enforcement To Deter Future Violations
FDA will consider prosecuting executives of firms making unapproved sexually transmitted disease treatment claims for OTC drugs and nutritional products, the targets of its latest enforcement sweep.